based biotech, known for its lifesaving coronavirus ... $1.7 billion. Moderna emerged from the pandemic as a standout corporate winner, as its vaccine supercharged its stock price and made ...
Moderna said on Thursday it had paused its plans to build a vaccine manufacturing facility in Kenya, following a ...
Pfizer Inc. and Moderna Inc. have raised the prices of their COVID-19 vaccines in their latest European Union supply contracts, the Financial Times reported on Sunday. The new price for the Pfizer ...
The phase 3 results bolster Moderna’s combination products, namely a lead COVID-flu combo vaccine that uses mRNA-1283. CEO Stephane Bancel said the data reinforce “confidence in our ability to ...
Five years from now, Moderna could be synonymous with personalised cancer vaccines, not Covid-19. Chief executive Stéphane Bancel talks with Scottish Mortgage manager Tom Slater about what can ...
It also had plans to start filling doses of its COVID vaccine in the continent as early as 2023. However, Moderna has not received ... Financecategory JPMorgan CEO Dimon sells about $33 mln ...
The Moderna (Nasdaq: MRNA) CEO’s compensation last year included a base salary of about $1.56 million, which was actually an increase ... vaccine-maker. The company saw a drop in interest in ...
Authors focused their research on those who received the COVID vaccine from Pfizer or Moderna and died within 100 days of receiving their shots. Only 40 deaths occurred in that window. Of the 40 ...
Covid vaccines from companies like Pfizer, Moderna and AstraZeneca were linked to rare occurrences of heart, brain and blood ...
LONDON: Pfizer Inc and Moderna Inc have raised the prices of their COVID-19 vaccines in their latest European Union supply contracts, the Financial Times reported ...